Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription 10.06.2024 1 Adv Radiat Oncol 1 Am J Clin Pathol 1 Am Soc Clin Oncol Educ Book 2 Arch Esp Urol 2 Arch Gynecol Obstet 2 Asian J Surg 1 Asian Nurs Res (Korean Soc Nurs Sci) 3 BMC Cancer 1 BMC Complement Med Ther 1 BMC Health Serv Res 2 BMC Infect Dis 3 BMC Womens Health 1 Cancer Biother Radiopharm 2 Cancer Cytopathol 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Med 1 Cell Commun Signal 1 Cell Death Discov 1 Cell Mol Biol (Noisy-le-grand) 2 CMAJ 1 Crit Rev Eukaryot Gene Expr 1 Diagn Interv Radiol 1 Diagn Pathol 1 Eur J Cancer Prev 1 Eur J Hum Genet 1 Eur J Obstet Gynecol Reprod Biol 1 Eur J Public Health 2 Front Immunol 4 Front Oncol 1 Front Public Health 1 Health Sci Rep 4 Heliyon 1 HLA 1 IEEE J Biomed Health Inform 2 Int J Gynecol Cancer 1 J Am Coll Radiol 1 J Cancer Res Clin Oncol 1 J Endocrinol Invest 1 J Health Care Poor Underserved 1 J Med Virol 2 J Obstet Gynaecol Res 1 J Racial Ethn Health Disparities 1 JAMA Intern Med 1 Med Phys 1 N Z Med J 1 Nat Med 1 Pathobiology 1 PeerJ 1 Pract Radiat Oncol 1 Quant Imaging Med Surg 1 Schizophr Bull 3 Sci Rep 1 Sex Health 2 Virol J 2 Zhonghua Bing Li Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Radiat Oncol

1. WANG G, Wang Z, Zhang Y, Sun X, et al
   Daily Online Adaptive Radiation Therapy of Postoperative Endometrial and Cervical Cancer With PTV Margin Reduction to 5 mm: Dosimetric Outcomes, Acute Toxicity, and First Clinical Experience.
   Adv Radiat Oncol. 2024;9:101510.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

2. HOU J, Belinson JL, Du H, Li C, et al
   AmpFire HPV and ScreenFire RS HPV validation trial.
   Am J Clin Pathol. 2024;161:535-542.
   PubMed         Abstract available
   
   

   
   Am Soc Clin Oncol Educ Book

3. MARTINEZ ME, Schmeler KM, Lajous M, Newman LA, et al
   Cancer Screening in Low- and Middle-Income Countries.
   Am Soc Clin Oncol Educ Book. 2024;44:e431272.
   PubMed         Abstract available
   
   

   
   Arch Esp Urol

4. WANG J, Lv N, Yang L, Zhu Y, et al
   Family Resilience and Its Influencing Factors in Patients with Stress Urinary Incontinence after Cervical Cancer Surgery: A Retrospective Study.
   Arch Esp Urol. 2024;77:397-404.
   PubMed         Abstract available
   
   
5. LIU G, Ye H, Chen W, Zhao W, et al
   Effect of Pelvic Floor Function Exercises Based on the ERAS Concept on Lower Urinary Tract Symptoms after Radical Hysterectomy for Cervical Cancer: A Retrospective Cohort Study.
   Arch Esp Urol. 2024;77:426-432.
   PubMed         Abstract available
   
   

   
   Arch Gynecol Obstet

6. KHAN I, Khare BK
   Exploring the potential of machine learning in gynecological care: a review.
   Arch Gynecol Obstet. 2024;309:2347-2365.
   PubMed         Abstract available
   
   
7. BIST R, Mohi MK, Garg R
   Colposcopic findings to study cervical changes in reproductive age group women using various contraceptives.
   Arch Gynecol Obstet. 2024;309:2799-2809.
   PubMed         Abstract available
   
   

   
   Asian J Surg

8. WANG Y, Lu J, Qiu H, Yang C, et al
   Post-surgery rapid metastasis in stage IB2 mixed adenoneuroendocrine cervical carcinoma: An insightful reflective case study.
   Asian J Surg. 2024;47:2967-2968.
   PubMed        
   
   
9. LIU J, Li S, Zhang Y, Cheng J, et al
   Gastric-type adenocarcinoma of the uterine cervix: A case report.
   Asian J Surg. 2024;47:2952-2953.
   PubMed        
   
   

   
   Asian Nurs Res (Korean Soc Nurs Sci)

10. YANG H, Zhang Y, Heng F, Li W, et al
    Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy.
    Asian Nurs Res (Korean Soc Nurs Sci). 2024;18:178-187.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. LI J, Yang Z, Wang T, Li M, et al
    Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
    BMC Cancer. 2024;24:667.
    PubMed         Abstract available
    
    
12. FEREDE YA, Tassew WC, Zeleke AM
    Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
    BMC Cancer. 2024;24:678.
    PubMed         Abstract available
    
    
13. ALI B, Galbarczyk A, Jasienska G, Ba-Break M, et al
    Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women.
    BMC Cancer. 2024;24:695.
    PubMed         Abstract available
    
    

    
    BMC Complement Med Ther

14. GUO M, Guo D, Liao L, Zhang X, et al
    Ethanolic extract from Sophora moorcroftiana inhibit cell proliferation and alter the mechanical properties of human cervical cancer.
    BMC Complement Med Ther. 2024;24:212.
    PubMed         Abstract available
    
    

    
    BMC Health Serv Res

15. LEWIS AGC, Hernandez DM, Garces-Palacio IC, Soliman AS, et al
    Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.
    BMC Health Serv Res. 2024;24:693.
    PubMed         Abstract available
    
    

    
    BMC Infect Dis

16. MOLINA MA, Leenders WPJ, Huynen MA, Melchers WJG, et al
    Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study.
    BMC Infect Dis. 2024;24:552.
    PubMed         Abstract available
    
    
17. KIPP B, Ulrich E, van Meegen C, Schwenzer T, et al
    Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
    BMC Infect Dis. 2024;24:558.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

18. KABANDA R, Kiconco A, Ronald A, Beyer KMM, et al
    Correction: Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
    BMC Womens Health. 2024;24:328.
    PubMed        
    
    
19. ONYANGO OE, Masinde D, Ouma C
    Enhancing cervical cancer knowledge among women of reproductive age: a dialogue-based community health education intervention in rural Kisumu County, Kenya.
    BMC Womens Health. 2024;24:327.
    PubMed         Abstract available
    
    
20. WORKU E, Yigizaw G, Admassu R, Mekonnen D, et al
    Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design.
    BMC Womens Health. 2024;24:322.
    PubMed         Abstract available
    
    

    
    Cancer Biother Radiopharm

21. HUA L, Wei M, Feng C, Li S, et al
    Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Cancer Biother Radiopharm. 2024 Jun 3. doi: 10.1089/cbr.2023.0199.
    PubMed         Abstract available
    
    

    
    Cancer Cytopathol

22. YE L, Gan M, Yao Y, Lu B, et al
    Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions.
    Cancer Cytopathol. 2024;132:340-347.
    PubMed         Abstract available
    
    
23. NIKAS IP, Souza da Silva R, Sousa-Pinto B, Schmitt F, et al
    Challenging the concept of "risk of malignancy" in cytology.
    Cancer Cytopathol. 2024;132:335-339.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

24. MWENDA V, McGrath CJ
    Choosing the Appropriate HPV Testing and Treatment Algorithm: What Works for Different Contexts?
    Cancer Epidemiol Biomarkers Prev. 2024;33:763-765.
    PubMed         Abstract available
    
    

    
    Cancer Med

25. DUN C, Yuan M, Zhao X, Hu S, et al
    Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.
    Cancer Med. 2024;13:e7316.
    PubMed         Abstract available
    
    

    
    Cell Commun Signal

26. PAN B, Liu C, Su J, Xia C, et al
    Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
    Cell Commun Signal. 2024;22:306.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

27. SUN HN, Ma DY, Guo XY, Hao YY, et al
    Peroxiredoxin I and II as novel therapeutic molecular targets in cervical cancer treatment through regulation of endoplasmic reticulum stress induced by bleomycin.
    Cell Death Discov. 2024;10:267.
    PubMed         Abstract available
    
    

    
    Cell Mol Biol (Noisy-le-grand)

28. YU J, Huang L, Cao L
    M2 macrophages regulate KDM6B/PFKFB2 metabolic reprogramming of cervical squamous cell carcinoma through CXCL1.
    Cell Mol Biol (Noisy-le-grand). 2024;70:78-84.
    PubMed         Abstract available
    
    

    
    CMAJ

29. CHARLEBOIS S, Kean S
    To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.
    CMAJ. 2024;196:E729-E730.
    PubMed        
    
    
30. PATAKY RE, Izadi-Najafabadi S, Smith LW, Gottschlich A, et al
    Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.
    CMAJ. 2024;196:E716-E723.
    PubMed         Abstract available
    
    

    
    Crit Rev Eukaryot Gene Expr

31. WANG R, Tan W
    RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:15-29.
    PubMed         Abstract available
    
    

    
    Diagn Interv Radiol

32. LI J, Niu C, Zhang L, Mu Y, et al
    Association of body composition and systemic inflammation for patients with locally advanced cervical cancer following concurrent chemoradiotherapy.
    Diagn Interv Radiol. 2024 Jun 3. doi: 10.4274/dir.2024.242751.
    PubMed         Abstract available
    
    

    
    Diagn Pathol

33. WEI X, Li L
    Cytological diagnosis of patients with embryonal rhabdomyosarcoma of the cervix: case report and literature review.
    Diagn Pathol. 2024;19:73.
    PubMed         Abstract available
    
    

    
    Eur J Cancer Prev

34. TROJNARSKA D, Jach R
    Primary prevention of HPV-related diseases from the patients' perspective in Poland.
    Eur J Cancer Prev. 2024;33:299-308.
    PubMed         Abstract available
    
    

    
    Eur J Hum Genet

35. ADEBAMOWO SN, Adeyemo A, Adebayo A, Achara P, et al
    Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections.
    Eur J Hum Genet. 2024;32:708-716.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

36. GARCIA JC, Maraver FM, Rodriguez Jimenez I, Rios-Pena L, et al
    Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:43-53.
    PubMed         Abstract available
    
    

    
    Eur J Public Health

37. BERZA N, Zodzika J, Kivite-Urtane A, Baltzer N, et al
    Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer.
    Eur J Public Health. 2024 May 31:ckae075. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Front Immunol

38. ZHANG X, Li J, Yang L, Zhu Y, et al
    Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.
    Front Immunol. 2024;15:1391524.
    PubMed         Abstract available
    
    
39. MA B, Ren C, Yin Y, Zhao S, et al
    Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Front Immunol. 2024;15:1411132.
    PubMed         Abstract available
    
    

    
    Front Oncol

40. YUE H, Li X, You J, Feng P, et al
    Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?
    Front Oncol. 2024;14:1365897.
    PubMed         Abstract available
    
    
41. YANG X, Gao C, Sun N, Qin X, et al
    An interpretable clinical ultrasound-radiomics combined model for diagnosis of stage I cervical cancer.
    Front Oncol. 2024;14:1353780.
    PubMed         Abstract available
    
    
42. LIANG M, Sheng L, Ke Y, Wu Z, et al
    Corrigendum: The research progress on radiation resistance of cervical cancer.
    Front Oncol. 2024;14:1430862.
    PubMed         Abstract available
    
    
43. LUVIAN-MORALES J, Gutierrez-Enriquez SO, Granados-Garcia V, Torres-Poveda K, et al
    Risk factors for the development of cervical cancer: analysis of the evidence.
    Front Oncol. 2024;14:1378549.
    PubMed         Abstract available
    
    

    
    Front Public Health

44. BATESON D, Ussher J, Strnadova I, Loblinzk J, et al
    Working together with people with intellectual disability to make a difference: a protocol for a mixed-method co-production study to address inequities in cervical screening participation.
    Front Public Health. 2024;12:1360447.
    PubMed         Abstract available
    
    

    
    Health Sci Rep

45. TSIGE AW, Beyene DA
    Cervical cancer: Challenges and prevention strategies: A narrative review.
    Health Sci Rep. 2024;7:e2149.
    PubMed         Abstract available
    
    

    
    Heliyon

46. LI L, Gopinath SCB, Lakshmipriya T, Subramaniam S, et al
    Zeolite-iron oxide integrated interdigitated electrode sensor for diagnosing cervical cancer.
    Heliyon. 2024;10:e31851.
    PubMed         Abstract available
    
    
47. YU H, He H, Liang X, Lin H, et al
    Robotic-assisted laparoscopic radical hysterectomy for early-stage cervical cancer: The more experienced the bedside assistant, the better?
    Heliyon. 2024;10:e31741.
    PubMed         Abstract available
    
    
48. JIANG X, Feng C, Sun W, Zhang T, et al
    The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.
    Heliyon. 2024;10:e31738.
    PubMed         Abstract available
    
    
49. NIMANI TD, Bayisa FS, Jimma SD, Assefa AT, et al
    Knowledge and attitude toward cervical cancer screening among women aged 30-49 years attending selected health facilities in Ethiopia: Using structural equation model.
    Heliyon. 2024;10:e31596.
    PubMed         Abstract available
    
    

    
    HLA

50. KAWASE K, Taguchi A, Ishizaka A, Lin J, et al
    Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
    HLA. 2024;103:e15509.
    PubMed         Abstract available
    
    

    
    IEEE J Biomed Health Inform

51. ZHANG Z, Yao P, Chen M, Zeng L, et al
    SCAC: A Semi-Supervised Learning Approach for Cervical Abnormal Cell Detection.
    IEEE J Biomed Health Inform. 2024;28:3501-3512.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

52. PAREJA R
    Vaginal radical trachelectomy: is now the end of an era?
    Int J Gynecol Cancer. 2024;34:806-807.
    PubMed        
    
    
53. NISTOR SI, El Tawab S, Zouridis A, Ferrari F, et al
    Minimally invasive surgery in the management of early stage cervical cancer after the publication of SHAPE trial.
    Int J Gynecol Cancer. 2024 May 31:ijgc-2024-005724.
    PubMed        
    
    

    
    J Am Coll Radiol

54. SHINAGARE AB, Burk KS, Kilcoyne A, Akin EA, et al
    ACR Appropriateness Criteria(R) Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update.
    J Am Coll Radiol. 2024;21.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

55. LI J, Hou F, Teng Z, Xia W, et al
    LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B.
    J Cancer Res Clin Oncol. 2024;150:294.
    PubMed         Abstract available
    
    

    
    J Endocrinol Invest

56. LIU J, Lyu Y, He Y, Ge J, et al
    Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    J Endocrinol Invest. 2024;47:1545-1557.
    PubMed         Abstract available
    
    

    
    J Health Care Poor Underserved

57. HANDLER A, Pham TND, Rankin K
    Women's Preventive Services Utilization in Illinois in the Aftermath of the ACA and the COVID-19 Pandemic.
    J Health Care Poor Underserved. 2024;35:672-691.
    PubMed         Abstract available
    
    

    
    J Med Virol

58. CHUNG PYJ, Dhillon SK, Baraquin A, Tkachenka Y, et al
    Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
    J Med Virol. 2024;96:e29688.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

59. KOBAYASHI O, Kamata S, Okuma Y, Nakajima T, et al
    Carcinogenesis and epidemiology of cervical cancer: The hallmark of human papillomavirus-associated cancer.
    J Obstet Gynaecol Res. 2024 Jun 5. doi: 10.1111/jog.15997.
    PubMed         Abstract available
    
    
60. SHI Y, Dong XY, Yimingjiang MWLD, Ma WM, et al
    The association between human papillomavirus infection, vaginal microecology, and cervical intraepithelial neoplasia in women from Xinjiang, China.
    J Obstet Gynaecol Res. 2024;50:982-990.
    PubMed         Abstract available
    
    

    
    J Racial Ethn Health Disparities

61. MOYCE S, Claudio D, Aghbashian E, Keenan K, et al
    Barriers and Facilitators to Breast and Cervical Cancer Screenings for Hispanic Women in a Rural State.
    J Racial Ethn Health Disparities. 2024 Jun 7. doi: 10.1007/s40615-024-02037.
    PubMed         Abstract available
    
    

    
    JAMA Intern Med

62. AMBOREE TL, Montealegre JR, Parker SL, Garg A, et al
    National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    JAMA Intern Med. 2024;184:671-679.
    PubMed         Abstract available
    
    

    
    Med Phys

63. GAUTAM S, Osman AFI, Richeson D, Gholami S, et al
    Attention 3D U-NET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Direction modulated brachytherapy tandem applicator.
    Med Phys. 2024 Jun 3. doi: 10.1002/mp.17238.
    PubMed         Abstract available
    
    

    
    N Z Med J

64. PATERSON H, Macfarlane E, Slater T, Stanton JL, et al
    Preliminary assessment of using mobile point-of-care human papillomavirus (HPV) testing with the option of immediate colposcopy in a rural area in a high-income country: a case study.
    N Z Med J. 2024;137:43-51.
    PubMed         Abstract available
    
    

    
    Nat Med

65. SCHREIBERHUBER L, Barrett JE, Wang J, Redl E, et al
    Cervical cancer screening using DNA methylation triage in a real-world population.
    Nat Med. 2024 Jun 4. doi: 10.1038/s41591-024-03014.
    PubMed         Abstract available
    
    

    
    Pathobiology

66. AL-AWADHI R, Alwehaidah MS, AlRoomy M, Kapila K, et al
    Relative Telomere Length in Cervical Exfoliated Cells among Women with High-Risk Human Papillomavirus.
    Pathobiology. 2024;91:180-186.
    PubMed         Abstract available
    
    

    
    PeerJ

67. WANG L, Dong Y
    Peripheral blood immune cell parameters in patients with high-grade squamous intraepithelial lesion (HSIL) and cervical cancer and their clinical value: a retrospective study.
    PeerJ. 2024;12:e17499.
    PubMed         Abstract available
    
    

    
    Pract Radiat Oncol

68. ANDRING LM, Corrigan KL, Reeve B, Meyer L, et al
    The value of patient-reported outcomes to predict for symptom burden and health-related quality of life after chemoradiation for cervical cancer: A prospective study.
    Pract Radiat Oncol. 2024 May 31:S1879-8500(24)00135.
    PubMed         Abstract available
    
    

    
    Quant Imaging Med Surg

69. ZHANG K, Yu B, Tang M, Li Y, et al
    Endovaginal coil for pelvic high-resolution magnetic resonance imaging of cervical cancer: a preliminary parameter optimization study.
    Quant Imaging Med Surg. 2024;14:3851-3862.
    PubMed         Abstract available
    
    

    
    Schizophr Bull

70. HWONG AR, Murphy KA, Vittinghoff E, Alonso-Fraire P, et al
    Cervical Cancer Screening Among Female Medicaid Beneficiaries With and Without Schizophrenia.
    Schizophr Bull. 2024 Jun 6:sbae096. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Sci Rep

71. LI W, Yu KN, Bao L, Shen J, et al
    Retraction Note: Non-thermal plasma inhibits human cervical cancer HeLa cells invasiveness by suppressing the MAPK pathway and decreasing matrix metalloproteinase-9 expression.
    Sci Rep. 2024;14:12785.
    PubMed        
    
    
72. LOVANE L, Tulsidas S, Carrilho C, Karlsson C, et al
    PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV.
    Sci Rep. 2024;14:12974.
    PubMed         Abstract available
    
    
73. AYANTO SY, Belachew T, Wordofa MA
    Effectiveness of couple education and counseling on uptake of cervical cancer screening among women in Southern Ethiopia: a cluster randomized trial.
    Sci Rep. 2024;14:12557.
    PubMed         Abstract available
    
    

    
    Sex Health

74. ZAMMIT CM, Brooks A, Brotherton JML, Nightingale CE, et al
    What young women (aged 24-29 years) in Australia think about self-collection for cervical screening: a brief report.
    Sex Health. 2024;21:SH24033.
    PubMed         Abstract available
    
    

    
    Virol J

75. MOVAHED F, Darzi S, Mahdavi P, Salih Mahdi M, et al
    The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV).
    Virol J. 2024;21:124.
    PubMed         Abstract available
    
    
76. BI D, Wei S, Luo X, Luo X, et al
    Management for persistent HPV infection and cervical lesions among women infected with HIV: a retrospective observational cohort study.
    Virol J. 2024;21:133.
    PubMed         Abstract available
    
    

    
    Zhonghua Bing Li Xue Za Zhi

77. ZHAO LN, Yuan JP, Huang AL, Wang CH, et al
    [Colorectal metastasis from female genital system neoplasm in colonoscopy biopsy specimen mimicking primary colorectum cancer: a clinicopathological analysis of ten cases].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:610-612.
    PubMed        
    
    
78. WEI X, Zheng Z, Shi QY, Wang CS, et al
    [Application of PRAME immunohistochemistry in the differential diagnosis of primary endometrial and endocervical adenocarcinomas].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:552-556.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.